David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Accel Entertainment
ACEL
$959M
| $1.23M | ﹤0.01% |
+114,975
| New | +$1.31M |
|
|
UCFI
2952
CN Healthy Food Tech Group
UCFI
| $1.22M | ﹤0.01% |
119,035
| – | – |
|
2953
STAAR Surgical
STAA
$1.15B
| $1.22M | ﹤0.01% |
+50,249
| New | +$1.43M |
|
2954
Telefônica Brasil
VIV
$18.6B
| $1.22M | ﹤0.01% |
161,549
+146,371
| +964% | +$1.3M |
|
|
RAPT
2955
DELISTED
RAPT Therapeutics
RAPT
| $1.22M | ﹤0.01% |
96,252
-34,771
| -27% | -$442K |
|
|
GPMT
2956
Granite Point Mortgage Trust
GPMT
$50.6M
| $1.21M | ﹤0.01% |
433,991
-134,940
| -24% | -$425K |
|
|
ALTM
2957
PUT
DELISTED
Arcadium Lithium plc
ALTM
| $1.21M | ﹤0.01% |
235,680
| – | – |
|
2958
MBIA
MBI
$256M
| $1.21M | ﹤0.01% |
186,828
-38,051
| -17% | -$196K |
|
2959
Tyson Foods
TSN
$19.9B
| $1.2M | ﹤0.01% |
+20,942
| New | +$1.27M |
|
2960
Strategic Education
STRA
$1.89B
| $1.2M | ﹤0.01% |
12,869
-13,718
| -52% | -$1.28M |
|
2961
PUT
Chemours
CC
$2.37B
| $1.2M | ﹤0.01% |
70,900
+50,400
| +246% | +$981K |
|
2962
Aurinia Pharmaceuticals
AUPH
$2.2B
| $1.2M | ﹤0.01% |
133,333
+39,384
| +42% | +$321K |
|
2963
CALL
Uranium Energy
UEC
$6.5B
| $1.19M | ﹤0.01% |
+178,100
| New | +$1.36M |
|
2964
Marcus Corp
MCS
$913M
| $1.19M | ﹤0.01% |
55,398
+8,267
| +18% | +$164K |
|
2965
Healthcare Realty
HR
$6.6B
| $1.19M | ﹤0.01% |
70,260
-571,953
| -89% | -$10.1M |
|
2966
3D Systems Corp
DDD
$548M
| $1.19M | ﹤0.01% |
362,978
+79,192
| +28% | +$252K |
|
2967
Independent Bank
INDB
$3.92B
| $1.19M | ﹤0.01% |
18,521
-96,785
| -84% | -$6.45M |
|
2968
Ingevity
NGVT
$2.39B
| $1.19M | ﹤0.01% |
29,150
-64,747
| -69% | -$2.7M |
|
2969
PUT
Camtek
CAMT
$6.69B
| $1.19M | ﹤0.01% |
14,700
+4,200
| +40% | +$330K |
|
2970
CALL
Prudential Financial
PRU
$41.5B
| $1.19M | ﹤0.01% |
10,000
| – | – |
|
2971
PUT
Cardinal Health
CAH
$55.4B
| $1.18M | ﹤0.01% |
10,000
| – | – |
|
2972
iShare MSCI Eurozone ETF
EZU
$9.95B
| $1.18M | ﹤0.01% |
25,035
+2,474
| +11% | +$121K |
|
2973
Tiptree Inc
TIPT
$687M
| $1.18M | ﹤0.01% |
56,592
+10,764
| +23% | +$225K |
|
2974
Sasol
SSL
$7.28B
| $1.18M | ﹤0.01% |
258,800
+168,030
| +185% | +$950K |
|
2975
Semtech
SMTC
$13.1B
| $1.18M | ﹤0.01% |
+19,010
| New | +$1M |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $7.08B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.